AstraZeneca reported decrease in its global revenue for the first half of 2011 mostly due to adverse market conditions in the US. In this context, how…
In Conversation
Taking a look at a key achievement of the ABPI in recent years, we recognize the role you played in negotiating the revised PPRS that was…
It are exciting times for the UK, with the public healthcare system undergoing so many changes. The Office of Life Sciences (OLS) and the Therapeutic Capability…
Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within…
Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed the evolution of the OTC market from…
Medichem began production at its plant in Malta in 2006. Can you give us a brief overview of the facilities, and of the importance of the…
Actavis’ Maltese operations began as far back as 1976 as a different company ( Pharmamed Ltd.). In 2001, this Malta facility was acquired by Actavis which…
Can you give us a brief description of Metallform’s activity since the establishment of the Maltese subsidiary in 1992? The parent company Metallform GmbH & Cokg…
Can you give our readers an overview of the main characteristics of the Maltese Pharmaceutical market for innovators? Hilary Agius: In a nutshell, in Malta there…
Combino Pharm began production at its plant in Malta in 2006. Can you give us a brief overview of the facilities, and of the importance of…
Sandoz has set important trends in the pharmaceutical market, first by creating a leading global generics business under the umbrella of parent company Novartis, and secondly…
You are specialised in Cardiology at Padua University, in Tropical Medicine and Hygiene at London University and in Pharmacology at Modena University, in Communication at Bocconi…
